Britannia Life Sciences Inc. (CNSX:BLAB) entered into an agreement to acquire additional 10% stake in Advanced Development & Safety Laboratories Limited on April 7, 2022. Upon completion of the Additional ADSL Purchase, Britannia will own a 70% interest in ADSL, Britannia's largest operating subsidiary. Gowling WLG (UK) LLP and Bennett Jones LLP acted as legal advisor to Britannia Life Sciences Inc.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 CAD | +40.00% | +40.00% | -6.67% |
1st Jan change | Capi. | |
---|---|---|
-6.67% | 5.93M | |
+20.87% | 8.44B | |
+7.54% | 7.78B | |
+12.95% | 6.77B | |
-3.86% | 3.81B | |
-5.81% | 3.71B | |
+2.08% | 1.4B | |
-27.10% | 1.09B | |
+24.00% | 1.03B | |
-12.18% | 901M |
- Stock Market
- Equities
- BLAB Stock
- News Britannia Life Sciences Inc.
- Britannia Life Sciences Inc. entered into an agreement to acquire additional 10% stake in Advanced Development & Safety Laboratories Limited.